Boston, MA -- (SBWIRE) -- 01/10/2013 -- GBI Research, the leading business intelligence provider, has released its latest research report: "Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes". The report examines how mHealth, which is the facilitation of health-related information through mobile-enabled technologies, has been applied by the pharmaceutical industry in drug development and by healthcare providers in the developed and emerging economies to improve healthcare services and treatment outcomes.

It looks in detail at the ways in which the pharmaceutical industry has utilized mobile technologies in patient recruitment, compliance and retention of clinical trials, its role in marketing and consumer education and the important developments in drug authentication and post-market surveillance.

View Full Report Details and Table of Contents

The report investigates how the healthcare system has migrated from a paper-based system to an electronic one and the innovative ways in which this can be used enhance the flow of medical information. It assesses the growing use of mobile health apps as reference and diagnostic tools to support decision-making and highlights how mHealth can improve communication between patients and healthcare providers; empowering patients to take a more active role in their health and improving the continuum of healthcare from the clinic to the home.

Lastly, the report examines how mHealth programs in the emerging economies and the developed world can help to bridge the gap within fragmented under-resourced healthcare systems. It highlights how technologies devised for the developed countries are not always suitable for the developing countries and the need for local communities to devise mHealth solutions to address local issues such as infectious diseases (dengue fever, AIDS/HIV and tuberculosis) and high infant and maternal mortality rates.

The report is built using information from primary and secondary research including interviews with experts in the field.

GBI Research's analysis concludes that mHealth has huge potential to bridge the gap within existing healthcare systems but highlights the significant differences in the rate of adoption of mHealth in the developed world compared to the developing countries due to their existing infrastructures and differing "doctor-centric" and "patient centric" approaches to healthcare.

The mHealth alliance has identified five critical areas that need to be addressed if mHealth is to become main stream in global health: evidence building, standards and interoperability, sustainable financing, capacity building and policy. This will only be achieved if all stakeholders (patients, healthcare professionals and providers, pharmaceutical industry, mobile network operators and governments) work together to determine the ways in which mHealth can add value and provide significant advantages over traditional routes of healthcare communication.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Alliance Healthcare Services, Inc. (AIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- BELLUS Health Inc (BLU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Genomic Health, Inc. (GHDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Patient Adherence, Communication and Engagement (PACE) - Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations and Encourage Compliance
- Cardinal Health, Inc. (CAH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- IMS Health Incorporated - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Phase Forward Incorporated (PFWD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Bioniche Life Sciences, Inc. (BNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- InSight Health Services Holdings Corp. (ISGTQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Elan Corporation, plc (ELN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile